Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C

Leukemia

Volumn 9, Issue 1, 1995, Pages 131-138

  Keith, Fionna J ^a   Bradbury, Dawn A ^a   Zhu, Yong Ming ^a   Russell, Nigel H ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

AML; Apoptosis; Ara C; bcl 2

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYTARABINE; MESSENGER RNA;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; BLAST CELL; CELL DEATH; CELL STRAIN HL 60; CHEMOSENSITIVITY; CHEMOTHERAPY; DRUG POTENTIATION; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 0028910558     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Cleary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 1986;47:19-28.
2. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1992;348:334-336.
3. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic survival and cooperates with c-myc to immortalise pre-B-cells. Nature 1988;335:440-446.
4. Delia D, Aiello A, Soligo D, Fontanella E, Melani C, Pezzella F, Pierotti MA, Porta GD. Bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 1992;79:1291-1298.
5. Zutter M, Hockenbery D, Silverman GA, Korsmeyer SJ. Immunolocalisation of the bcl-2 protein within haemopoietic neoplasms. Blood 1991;81:3091-3096.
6. Campos L, Rouault J-P, Sabiolo O, Oriol P, Roubi N, Vasselan C, Archimbaud E. High expression of bcl-2 protein in acute myeloid leukaemia cells is associated with poor response to chemotherapy. Blood 1993;81:3091-3096.
7. Hunter AE, Rogers SY, Reilly IAG, Barrett AJ, Russell NH. Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemia. Blood 1993;82:899-903.
8. Lowenberg B, van Rotten WLJ, Touw I, Dewel R, Santini V. Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult myeloid leukemia. New Engl J Med 1992; 328:614-619.
9. Reilly JAC, Kozlowski R, Russell NH. Heterogenous mechanisms of autocrine growth of AML blasts. Br J Haematol 1989; 72:363-369.
10. Bradbury D, Zhu Y-M, Russell N. Regulation of bcl-2 expression and apoptosis in acute myeloblastic leukaemia cells by granulocyte-macrophage colony-stimulating factor. Leukemia 1994;8: 786-791.
11. Lotem J, Sachs L. Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation competent and defective myeloid leukemic cells. Cell Growth Differ 1993;4:41-47.
12. Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 1993;81:151-157.
13. Reed JC, Stein C, Subasinghe C, Haldar S, Croce CM, Yum S, Cohen J. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res 1990;50: 6565-6570.
14. Kitada S, Miyashita T, Tanaka S, Reed JC. Investigations of antisense oligonucleotides targeted against bcl-2 RNAs. Antisense Res Devel 1993;3:157-169.
15. Finke J, Fritzen R, Ternes P, Trivedi P, Bross KJ, Lange W, Mertelsmann R. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Blood 1992;80:459-469.
16. Bennet J, Catovsky D, Daniel M, Flandrin C, Galton DAG, Gralnick HR, Sultan C. Proposals for the classification of the acute leukaemias. Br J Haematol 1976;33:451-458.
17. Chomczynski P, Sacchi N. Single step methods of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
18. Arends MJ, Whyllie AH. Apoptosis: mechanisms and roles in pathology, Int Rev Exp Pathol 1991;32:223-254.
19. Zamai L, Falcieri E, Zauli C, Cataldi A, Vitale M. Optimal detection of apoptosis by flow cytometry depends on cell morphology. Cytometry 1993;14:891-897.
20. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Method 1991;139:271-279.
21. Young IT. Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. J Histochem Cytochem 1977;25:935-941.
22. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75:241-251.
23. Darzynkiewicz Z, Bruno S, Del Bino C, Gorczyca W, Hotz MA, Lassota P, Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry 1992;13:795-808.
24. Reilly IAG, Kozlowski R, Russell NH. The role of cell contact and autostimulatory soluble factors in the proliferation of blast cells in acute myeloblastic leukaemia. Leukemia 1988;3:145-150.
25. Nunez C, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ. Dysregulated bcl-2 gene expression selectively prolongs the survival of growth-factor deprived hemopoietic cell lines. J Immunol 1990;144:3602-3610.
26. Bradbury D, Rogers IS, Reilly AG, Kozlowski R, Russell NH. Role of autocrine and paracrine production of granulocyte-macrophage colony-stimulating factor and Interleukin-1β in the autonomous growth of acute myeloblastic leukaemia cells' studies using purified CD34-positive cells. Leukemia 1992;6:552-556.